The PGXL Multi-Drug Sensitivity Panel
While we test individual genes, the real benefit of pharmacogenomics lies in the interplay between multiple genes and multiple drugs. PGXL’s broad spectrum drug sensitivity panel gives a unique, 360-degree view of each patient. It covers the genes known to determine the efficacy of 95% of medications, identifies patients susceptible to adverse events and red-flags drug interactions that complicate the patient’s care.
In addition to the panel, PGXL tests individual genes for both clinical and research purposes. Below is a list of tests currently available.
Molecular Oncology – For Research Inquiries Only
For sample collection and ordering instructions, download our Collection and Shipment Guide